
|Slideshows|August 2, 2017
Tips for Enhancing Disease-Modifying Therapy Adherence in Multiple Sclerosis
Author(s)Kyla McKay, BSc, PhD Candidate
Adherence is a major concern for clinicians across all disciplines. Even the most effective treatment will not be successful if the patients does not adhere to the prescribed treatment strategy. Inside learn more about the problem and ways to maximize adherence.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-IL6R Therapy Effective in Reducing NMOSD and MOGAD Disease Activity
2
Phase 3 EMBARK Data Released, CTE Associated with Dementia Risk, Pilavapadin Heads to Phase 3 Pain Studies
3
NeurologyLive® Brain Games: February 1, 2025
4
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia
5










